This provider's $9.7M in total Medicare payments ranks in the 90th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 7842% from 2015 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1273% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2015 | $124.17 | $23.95 | 5.18x | $100.22 | $15.3K | 669 | 669 |
| 2016 | $288.97 | $68.78 | 4.20x | $220.19 | $210.4K | 3.0K | 1.6K |
| 2017 | $1.1K | $165.94 | 6.65x | $937.97 | $118.5K | 625 | 259 |
| 2018 | $2.1K | $196.74 | 10.75x | $1.9K | $279.2K | 1.4K | 623 |
| 2019 | $134.80 | $38.37 | 3.51x | $96.43 | $2.8M | 40.7K | 31.9K |
| 2020 | $115.99 | $37.43 | 3.10x | $78.56 | $2.1M | 30.8K | 19.6K |
| 2021 | $115.74 | $34.50 | 3.35x | $81.24 | $1.6M | 24.0K | 17.2K |
| 2022 | $82.26 | $31.29 | 2.63x | $50.97 | $1.4M | 18.7K | 10.7K |
| 2023 | $75.75 | $53.47 | 1.42x | $22.28 | $1.2M | 11.1K | 6.1K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test def 22+ classes | 10.0K | $2.4M | $241.30 | 4.60x |
| G0482 | Drug test def 15-21 classes | 10.9K | $2.1M | $194.62 | 4.02x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 18.3K | $1.6M | $86.99 | 1.72x |
| 87483 | Test for detecting nucleic acid of organism causing infection of central nervous system | 1.0K | $455.8K | $451.69 | 1.58x |
| 87633 | Detection test for multiple types of respiratory virus | 887 | $401.7K | $452.90 | 1.63x |
| 80307 | Testing for presence of drug | 5.4K | $333.0K | $61.67 | 3.26x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 9.3K | $231.2K | $24.84 | 1.51x |
| G0481 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 908 | $139.1K | $153.14 | 7.35x |
| 87798 | Detection test for organism | 3.3K | $121.1K | $36.18 | 1.36x |
| 87481 | Detection test for candida species (yeast) | 2.5K | $91.9K | $36.14 | 1.32x |
| 87641 | Detection test for Staphylococcus aureus, methicillin resistant (MRSA bacteria) | 2.5K | $90.0K | $36.11 | 1.64x |
| 87640 | Detection test for Staphylococcus aureus (bacteria) | 2.5K | $88.5K | $35.58 | 1.49x |
| 87505 | Detection test for digestive tract pathogen | 578 | $80.7K | $139.64 | 2.16x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 638 | $72.0K | $112.91 | 3.66x |
| 87500 | Detection test for Vancomycin resistance strep (VRE) | 1.9K | $69.0K | $35.85 | 1.55x |
| 87653 | Detection test for Strep (Streptococcus, group B) | 1.8K | $63.8K | $35.01 | 1.29x |
| 87486 | Detection test for Chlamydia pneumoniae | 1.7K | $60.8K | $36.75 | 1.46x |
| 87581 | Detection test for Mycoplasma pneumoniae (bacteria) | 1.7K | $60.8K | $36.74 | 1.48x |
| 87491 | Detection test for chlamydia | 1.5K | $56.1K | $36.66 | 1.68x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2K | $51.7K | $23.45 | 1.20x |
This provider submits charges 3.24 times higher than what Medicare actually pays.
A markup ratio of 3.24x means for every $100 Medicare pays, this provider initially charges $324. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in IN for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Patients Choice Laboratories Of Indiana, Llc | Indianapolis, IN | $70.5M | ✓ Clear |
| Professional Clinical Laboratories, Llc | Hammond, IN | $70.1M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data